Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-07-19 @ 11:44 AM
Study NCT ID:
NCT02765269
Status:
COMPLETED
Last Update Posted:
2016-12-05
First Post:
2016-04-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intelligent Pain Management System for Assessing Pain in Cancer Patients
Sponsor:
Xinhua Translational Institute for Cancer Pain, Shanghai
Organization:
Study Overview
Official Title:
Development and Testing of an Intelligent Pain Management System (IPMS) for Chinese Patients With Cancer
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether the Intelligent Pain Management System (IPMS) could make recording and interfering pain timely among cancer patients with pain. The system's usability, feasibility, compliance, and satisfaction will also be assessed.
Detailed Description:
Research indicate that over one-third of cancer patients experienced cancer pain, which is known as a major reason leading to lower quality of life of the patients.In this present study, the investigators aim to design, develop, and test the feasibility of a low cost, conveniently implemented mobile application to facilitate real-time pain recording and timely intervention among Chinese cancer patients with pain. This system evaluate real-time pain and Karnofsky Performance Status（KPS）scores for quality of life, and to generate an action plan to visit the physician or to adjust pain medication dosage when the pain threshold is reached. The investigators study is to test this system's effectiveness.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: